ATE419846T1 - Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese - Google Patents

Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese

Info

Publication number
ATE419846T1
ATE419846T1 AT04708802T AT04708802T ATE419846T1 AT E419846 T1 ATE419846 T1 AT E419846T1 AT 04708802 T AT04708802 T AT 04708802T AT 04708802 T AT04708802 T AT 04708802T AT E419846 T1 ATE419846 T1 AT E419846T1
Authority
AT
Austria
Prior art keywords
analogas
erythropoiesis
stimulators
glycerides
fatty acids
Prior art date
Application number
AT04708802T
Other languages
English (en)
Inventor
Christopher Penney
Lyne Gagnon
Pierre Laurin
Boulos Zacharie
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Application granted granted Critical
Publication of ATE419846T1 publication Critical patent/ATE419846T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04708802T 2003-02-07 2004-02-06 Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese ATE419846T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44545403P 2003-02-07 2003-02-07

Publications (1)

Publication Number Publication Date
ATE419846T1 true ATE419846T1 (de) 2009-01-15

Family

ID=32850990

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04708802T ATE419846T1 (de) 2003-02-07 2004-02-06 Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese

Country Status (28)

Country Link
US (1) US9682054B2 (de)
EP (1) EP1592416B1 (de)
JP (1) JP5390070B2 (de)
KR (1) KR101120775B1 (de)
CN (1) CN100427081C (de)
AP (1) AP2005003367A0 (de)
AR (1) AR043120A1 (de)
AT (1) ATE419846T1 (de)
AU (1) AU2004210193B2 (de)
BR (1) BRPI0407276A (de)
CA (1) CA2515160C (de)
CY (1) CY1108963T1 (de)
DE (2) DE602004018902D1 (de)
DK (1) DK1592416T3 (de)
EA (1) EA009939B1 (de)
ES (1) ES2255467T3 (de)
IL (1) IL170057A (de)
JO (1) JO2705B1 (de)
MA (1) MA27664A1 (de)
MX (1) MXPA05008382A (de)
MY (1) MY140913A (de)
NO (1) NO334085B1 (de)
NZ (1) NZ541593A (de)
PT (1) PT1592416E (de)
SI (1) SI1592416T1 (de)
TN (1) TNSN05189A1 (de)
WO (1) WO2004069237A1 (de)
ZA (1) ZA200506246B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1900364T3 (da) * 2001-04-18 2014-01-13 Prometic Biosciences Inc Fedtsyrer, glycerider og analoger med medium kædelængde som neutrofile overlevelses- og aktiveringsfaktorer
CA2563533C (en) * 2004-04-15 2013-10-01 Shmuel A. Ben-Sasson Compositions capable of facilitating penetration across a biological barrier
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
JP2008507288A (ja) 2004-07-23 2008-03-13 アクセルロン ファーマ インコーポレーテッド ＡｃｔＲＩＩ受容体ポリペプチド、方法、および組成物
AP2007003939A0 (en) * 2004-09-03 2007-04-30 Prometic Biosciences Inc Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides
EA200700741A1 (ru) 2004-10-01 2007-08-31 Прометик Байосайенсиз Инк. Жирные спирты со средней длиной цепи как стимуляторы гематопоэза
US8071580B2 (en) * 2004-10-01 2011-12-06 Prometic Biosciences Inc. Medium-chain length fatty alcohols as stimulators of hematopoiesis
BRPI0618947B1 (pt) 2005-11-23 2022-07-19 Acceleron Pharma Inc Polipeptídeo actriia que se liga à ativina, polinucleotídeo isolado, polinucleotídeo recombinante, métodopara preparar um polipeptídeo actriia que se liga à ativina, preparação farmacêutica e uso de uma proteína de fusão actriia-fc para promover o crescimento ósseo e inibir a ressorção óssea
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
TWI584815B (zh) 2007-02-01 2017-06-01 艾瑟勒朗法瑪公司 活化素-ＡｃｔＲＩＩａ拮抗劑及其治療或預防乳癌之用途
TW201627320A (zh) 2007-02-02 2016-08-01 艾瑟勒朗法瑪公司 衍生自ＡｃｔＲＩＩＢ的變體與其用途
MX2009008510A (es) 2007-02-09 2010-01-15 Acceleron Pharma Inc Antagonistas de activina-actriia y usos para promover el crecimiento de huesos en pacientes con cancer.
CA2699936A1 (en) 2007-09-18 2009-03-26 Acceleron Pharma Inc. Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion
US9532962B2 (en) 2007-11-02 2017-01-03 Prometic Pharma Smt Limited Medium-chain length fatty acids and glycerides as nephroprotection agents
JP5473937B2 (ja) * 2007-12-19 2014-04-16 プロメティック・バイオサイエンシーズ・インコーポレイテッド 膵臓癌の治療のためのゲムシタビンと併用した中鎖脂肪酸、その塩およびトリグリセリド
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
DK3750552T5 (da) 2008-08-14 2024-08-26 Acceleron Pharma Inc Gdf-fælder
RU2678833C2 (ru) * 2008-09-17 2019-02-04 Киазма Инк. Фармацевтические композиции и соответствующие способы доставки
MX355042B (es) 2009-06-08 2018-04-02 Acceleon Pharma Inc Metodos para aumentar adipositos termogenicos.
CN107267520A (zh) 2009-06-12 2017-10-20 阿塞勒隆制药公司 截短的actriib‑fc融合蛋白
KR102170682B1 (ko) * 2009-08-13 2020-10-28 악셀레론 파마 인코포레이티드 적혈구 수준을 증가시키기 위한 ｇｄｆ 트랩과 에리트로포이에틴 수용체 활성인자의 병용
ES2658292T3 (es) 2009-11-17 2018-03-09 Acceleron Pharma, Inc. Proteínas ActRIIB y variantes y usos de las mismas con respecto a la inducción de la utrofina para el tratamiento de la distrofia muscular
CA2817008A1 (en) 2010-11-08 2012-05-18 Acceleron Pharma Inc. Actriia binding agents and uses thereof
TWI572352B (zh) * 2012-03-01 2017-03-01 波麥堤克藥學Ｓｍｔ有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法
RU2678117C2 (ru) 2012-11-02 2019-01-23 Селджин Корпорейшн Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений
CN102973922B (zh) * 2012-12-18 2016-02-03 华东理工大学 一种融合蛋白的应用
CN114699529A (zh) 2014-06-13 2022-07-05 阿塞勒隆制药公司 用于治疗溃疡的方法和组合物
MA41052A (fr) 2014-10-09 2017-08-15 Celgene Corp Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
EP3227675B1 (de) 2014-12-03 2023-03-15 Celgene Corporation Activin-actrii-antagonisten und verwendungen davon zur behandlung von myelodysplastischem syndrom
SI3253401T1 (sl) 2015-02-03 2025-07-31 Amryt Endo, Inc. Zdravljenje akromegalije z oralnim oktreotidom
US20170021029A1 (en) * 2015-04-15 2017-01-26 Jeffrey Charles Raber Topical formulations and uses
MA53188A1 (fr) 2018-10-11 2021-12-31 Basf As Composés aromatiques et leurs utilisations pharmaceutiques
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871768A (en) 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US7307166B1 (en) 1987-10-28 2007-12-11 Wellstat Therapeutics Corporation Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis
US5011852A (en) 1988-07-25 1991-04-30 Applied Analytical Industries, Inc. Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
JP3014119B2 (ja) * 1990-05-28 2000-02-28 雪印乳業株式会社 直腸投与用赤血球造血剤
JP3249147B2 (ja) 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
ATE147976T1 (de) * 1991-01-15 1997-02-15 Hemosphere Inc Protein nanomatrizen und verfahren zur herstellung
JPH05163160A (ja) 1991-12-13 1993-06-29 Snow Brand Milk Prod Co Ltd 免疫低下に伴う感染症の予防及び治療用栄養剤
US5214035A (en) 1992-04-16 1993-05-25 Hoechst-Roussel Agri-Vet Company Thixotropic formulations
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
AU7082694A (en) * 1994-05-10 1995-11-29 Kitasato Institute, The Hematopoietic stem cell proliferation accelerator
US5470861A (en) 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
US5549905A (en) 1994-10-18 1996-08-27 Clintec Nutrition Co. Enternal composition for pediatric patients
JPH08208510A (ja) 1994-11-03 1996-08-13 F Hoffmann La Roche Ag インターフェロン組成物
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
AUPN933396A0 (en) 1996-04-17 1996-05-09 Pfizer Pty Limited Non-aqueuos oral-drench compositions containing avermectin compounds
US5851534A (en) 1996-05-03 1998-12-22 Dynagen, Inc. Methods for prevention and/or treatment of neutropenia
JPH10265380A (ja) 1997-03-17 1998-10-06 Bristol Myers Squibb Co 抗ガン剤
EP1009383A1 (de) * 1997-09-04 2000-06-21 Biozone Laboratories, Inc. Orale liposomale verabreichungssysteme
AU752802C (en) * 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
CA2311124A1 (en) 1997-11-19 1999-05-27 Hercules Incorporated Fluidized polymer suspensions of cationic polysaccharides in emollients and use thereof in preparing personal care compositions
DE69833333T2 (de) * 1997-11-20 2006-10-19 Jhon, Gil Ja Pharmazeutische zusammensetzung enthaltend geweihextrakte von cervus nippon mit wachstumsstimulierender aktivität auf hematopoietische stammzellen und megakaryozyten
PT937456E (pt) * 1998-02-23 2004-10-29 Cilag Ag Int Dispersao lipossomal de eritropoietina
KR20010041696A (ko) 1998-03-11 2001-05-25 그레랑 파마수티컬 가부시키가이샤 발포성 장용(腸溶) 제제
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
CA2385989A1 (en) 1999-09-27 2001-04-05 Andrew Nienstedt Compositions of tocol-soluble therapeutics
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
DE60123603T2 (de) 2000-06-14 2007-08-16 William Leslie Diss Porter Lipide zur änderung des abwehrsystems
US6967028B2 (en) 2000-07-31 2005-11-22 Mainelab Prolonged release microspheres for injectable administration
IL142535A0 (en) 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
DK1900364T3 (da) * 2001-04-18 2014-01-13 Prometic Biosciences Inc Fedtsyrer, glycerider og analoger med medium kædelængde som neutrofile overlevelses- og aktiveringsfaktorer
US20040052836A1 (en) 2002-09-13 2004-03-18 Li Luk Chiu Pharmaceutical compositions containing at least one stable liposphere having an improved shelf life
US6725510B1 (en) 2003-04-25 2004-04-27 Almetta Clyburn Inclining coffin
PL1648851T3 (pl) 2003-07-25 2007-09-28 Prometic Biosciences Inc Wytwarzanie soli średniołańcuchowych kwasów tłuszczowych z metalami
AP2007003939A0 (en) 2004-09-03 2007-04-30 Prometic Biosciences Inc Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides
US8071580B2 (en) 2004-10-01 2011-12-06 Prometic Biosciences Inc. Medium-chain length fatty alcohols as stimulators of hematopoiesis

Also Published As

Publication number Publication date
ES2255467T3 (es) 2009-05-01
AU2004210193B2 (en) 2007-07-12
NZ541593A (en) 2009-05-31
US20060128800A1 (en) 2006-06-15
AR043120A1 (es) 2005-07-20
MY140913A (en) 2010-01-29
MXPA05008382A (es) 2005-11-04
US9682054B2 (en) 2017-06-20
CA2515160A1 (en) 2004-08-19
JP5390070B2 (ja) 2014-01-15
EA009939B1 (ru) 2008-04-28
SI1592416T1 (sl) 2009-06-30
ZA200506246B (en) 2006-12-27
AU2004210193A1 (en) 2004-08-19
CA2515160C (en) 2013-01-08
CN1753665A (zh) 2006-03-29
CY1108963T1 (el) 2014-07-02
KR101120775B1 (ko) 2012-04-18
TNSN05189A1 (en) 2007-06-11
WO2004069237A1 (en) 2004-08-19
DE602004018902D1 (de) 2009-02-26
NO20053994D0 (no) 2005-08-26
IL170057A (en) 2011-09-27
KR20050118671A (ko) 2005-12-19
CN100427081C (zh) 2008-10-22
NO334085B1 (no) 2013-12-09
JO2705B1 (ar) 2014-03-15
PT1592416E (pt) 2009-04-03
EA200501267A1 (ru) 2006-02-24
AP2005003367A0 (en) 2005-09-30
DK1592416T3 (da) 2009-04-20
MA27664A1 (fr) 2005-12-01
EP1592416A1 (de) 2005-11-09
NO20053994L (no) 2005-10-06
EP1592416B1 (de) 2009-01-07
DE04708802T1 (de) 2006-06-22
BRPI0407276A (pt) 2006-01-31
JP2006516987A (ja) 2006-07-13
ES2255467T1 (es) 2006-07-01

Similar Documents

Publication Publication Date Title
DE602004018902D1 (de) Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese
FI20021947A7 (fi) Menetelmä triglyseridien rasvahappoketjukoostumuksen säätämiseksi sekä menetelmän käyttö
IL183246A0 (en) Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
NO20031797L (no) Heteroarylalkylpiperazin-derivater som fettsyreoksidasjonsinhibitorer
DE69906875D1 (de) Triglyceride und diese enthaltende Kompositionen
DE60225081D1 (de) Herstellungsverfahren von Esterwachs
DE60130083D1 (de) Herstellung von Estern für die Verwendung als Basisschmieröl
DK1755565T3 (da) Blød gelatinekapsel omfattende polyumættede omega-3-fedtsyrer
SI1773312T1 (sl) Sestavek, ki vsebuje statine in maščobne kisline omega-3
NO20034490D0 (no) Fremgangsmåte for sammensetting av absorberende gjenstand til personlig stell
NO20023879L (no) Partielle fettsyre-oksydasjonsinhibitorer i behandlingen av kongestiv hjertesvikt
NO20025456D0 (no) Lipase-katalysert forestring av marine oljer
MX2010003568A (es) Composiciones y metodos para mejorar la funcion cognitiva.
AU2003281542A8 (en) Preparation of microbial oil containing polyunsaturated fatty acids
EP1625208A4 (de) Neues lipolytisches enzym lip2
DE69929811D1 (de) Quaternäre dialkylammoniumderivate von ölen, fettsäuren und triglyceriden und ihre anwendung in körperpflegeprodukten
DE602004022034D1 (de) Herstellung von konjugierten linolsäuren und linolsäuresalzen
DE602004006137D1 (de) Herstellung von metallsalzen von fettsäuren mit mittlerer kettenlänge
DE59913680D1 (de) Fettsäurepartialester von Polyolen
DE60020335D1 (de) Faserige matrix zum absorbieren von fett und öl
DE502006006986D1 (de) Azolopyridin-2-on-derivate als inhibitoren von lipasen und phospholipasen
ATE217389T1 (de) Verbrennung von fetten und ölen
ATA73099A (de) Singlet sauerstoff oxidation von organischen substanzen
DE69902715D1 (de) Als Öl vorliegende Fluorsilicone und ihre Verwendung in der Kosmetik.
DE502006008717D1 (de) Benzothiazol-2-on-derivate als inhibitoren von lipasen und phospholipasen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1592416

Country of ref document: EP